Shoulder RFA Pilot Study

Inclusion Criteria: 1. ≥50 years old capable of understanding and providing consent in English, and capable of complying with the outcome instruments used 2. ≥3 months of shoulder pain refractory to conventional treatment (i.e., physiotherapy, medication, steroid injections) 3. Persistent shoulder pain ≥ 4/10 in intensity on a 7-day average 4. Shoulder pain refractory to conventional treatment (i.e., physical therapy, oral analgesics, steroid injection) 5. Prior consultation with a board-certified orthopedic shoulder surgeon, deemed a non-surgical candidate for the primary diagnosis of glenohumeral joint pain +/- rotator cuff pain 6. ≥80% pain relief for at least 30 minutes after a single fluoroscopically-guided block of the sensory branches of the SN, AN, and LPN with 0.5 mL of lidocaine at each nerve 7. Scheduled for procedure of interest Exclusion Criteria: 1. Infection 2. Allergy to any medication needed to participate in this study 3. Previous partial/total/reverse shoulder arthroplasty. Participants with a history of RTC repair will not be excluded. 4. Neurologic disorders including radiculopathy, connective tissue/inflammatory joint disease/widespread soft tissue pain disorder 5. Severe, uncontrolled psychiatric disorder requiring hospitalization within 6 months 6. Intraarticular or subacromial injection to the study shoulder within 3 months before C-SRFA 7. Uncontrolled bleeding diathesis 8. Pregnancy 9. Pacemaker, neurostimulator, or other implanted device potentially sensitive to RF energy 10. Active Worker's compensation claim, litigation, or other possible reason for secondary gain. 11. Prior shoulder radiofrequency ablation 12. Daily opioid use